Serotonin Reuptake Inhibitors May Improve Obstructive Sleep Apnea in Depression With and Without Epilepsy

April 22, 2018

A study of adults with both obstructive sleep apnea (OSA) and depression has demonstrated a link between the use of serotonin reuptake inhibitors (SRIs) and reduced severity of OSA in subjects with and without epilepsy. However, those with epilepsy displayed a more significant correlation between SRI use and reduced severity of OSA. This research was presented at the 70th annual American Academy of Neurology meeting, held April 21-27, 2018, in Los Angeles, California.

The results suggest that SRIs may serve as a potential treatment for OSA and depression, both in patients with and without epilepsy.